Tapewire

Nasdaq · USD

AGIO

AGIOS PHARMACEUTICALS, INC.

Export transactions ↓
Tapewire entity
4499
SEC CIK
0001439222
Parsed reports
520

Last 12 months

Inside the activity.

0 purchase rows · 39 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202506
Jan 202601
Feb 202600
Mar 2026021
Apr 202607
May 202600
Jun 202600
Jul 202601
Aug 202601
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 27, 2023 Filed Mar 1, 2023 21:06 UTC SaleCommon stock 20,000 $25.37 $507,400.00
Disclosure

SEC source: 0001439222-23-000041 · wf-form4_167770476285855.xml · nonDerivative · entry 2

Schenkein David P · CIK 0001578200 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,879

F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $25.11 to $25.74. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:06 UTC Exercise / conversionCommon stock 20,000 $9.05 $181,000.00
Disclosure

SEC source: 0001439222-23-000041 · wf-form4_167770476285855.xml · nonDerivative · entry 1

Schenkein David P · CIK 0001578200 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,879

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
February 16, 2023 Filed Feb 16, 2023 21:03 UTC Tax withholdingCommon stock 3,648 $28.91 $105,463.68
Disclosure

SEC source: 0001439222-23-000024 · wf-form4_167658141141317.xml · nonDerivative · entry 2

FOUSE JACQUALYN A · CIK 0001405288 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,582

Read SEC document
February 16, 2023 Filed Feb 16, 2023 21:04 UTC
Burns James WilliamChief Legal Officer
Tax withholdingCommon stock 609 $28.91 $17,606.19
Disclosure

SEC source: 0001439222-23-000025 · wf-form4_167658143694129.xml · nonDerivative · entry 2

Burns James William · CIK 0001900772 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,538

Read SEC document
February 16, 2023 Filed Feb 21, 2023 21:05 UTC
Washburn Theodore James Jr.Principal Accounting Officer
SaleCommon stock 233 $27.21 $6,339.93
Disclosure

SEC source: 0001439222-23-000028 · wf-form4_167701349283143.xml · nonDerivative · entry 1

Washburn Theodore James Jr. · CIK 0001874199 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,668

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
February 14, 2023 Filed Feb 14, 2023 21:07 UTC
Gheuens SarahChief Medical Officer
Tax withholdingCommon stock 758 $28.44 $21,557.52
Disclosure

SEC source: 0001439222-23-000017 · wf-form4_167640880440163.xml · nonDerivative · entry 2

Gheuens Sarah · CIK 0001881190 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,009

Read SEC document
February 14, 2023 Filed Feb 14, 2023 21:07 UTC
Burns James WilliamChief Legal Officer
Tax withholdingCommon stock 643 $28.44 $18,286.92
Disclosure

SEC source: 0001439222-23-000018 · wf-form4_167640884813599.xml · nonDerivative · entry 2

Burns James William · CIK 0001900772 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,409

Read SEC document
February 14, 2023 Filed Feb 14, 2023 21:06 UTC
Washburn Theodore James Jr.Principal Accounting Officer
Tax withholdingCommon stock 273 $28.44 $7,764.12
Disclosure

SEC source: 0001439222-23-000016 · wf-form4_167640875313872.xml · nonDerivative · entry 2

Washburn Theodore James Jr. · CIK 0001874199 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,172

Read SEC document
February 14, 2023 Filed Feb 16, 2023 21:03 UTC Exercise / conversionRestricted stock units · Derivative 11,333 $0.00 $0.00
Disclosure

SEC source: 0001439222-23-000024 · wf-form4_167658141141317.xml · derivative · entry 3

FOUSE JACQUALYN A · CIK 0001405288 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common stock · 11,333 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments.

F2 · derivative.expiration_date: The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 21:03 UTC Exercise / conversionCommon stock 11,333 $0.00 $0.00
Disclosure

SEC source: 0001439222-23-000024 · wf-form4_167658141141317.xml · nonDerivative · entry 1

FOUSE JACQUALYN A · CIK 0001405288 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,230

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 21:04 UTC
Washburn Theodore James Jr.Principal Accounting Officer
Exercise / conversionRestricted stock units · Derivative 360 $0.00 $0.00
Disclosure

SEC source: 0001439222-23-000026 · wf-form4_167658147701426.xml · derivative · entry 4

Washburn Theodore James Jr. · CIK 0001874199 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common stock · 360 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F3 · derivative.exercise_date: The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments.

F3 · derivative.expiration_date: The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 21:04 UTC
Washburn Theodore James Jr.Principal Accounting Officer
SaleCommon stock 504 $28.59 $14,409.36
Disclosure

SEC source: 0001439222-23-000026 · wf-form4_167658147701426.xml · nonDerivative · entry 3

Washburn Theodore James Jr. · CIK 0001874199 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,901

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 21:04 UTC
Washburn Theodore James Jr.Principal Accounting Officer
Tax withholdingCommon stock 127 $28.91 $3,671.57
Disclosure

SEC source: 0001439222-23-000026 · wf-form4_167658147701426.xml · nonDerivative · entry 2

Washburn Theodore James Jr. · CIK 0001874199 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,405

Read SEC document
February 14, 2023 Filed Feb 16, 2023 21:04 UTC
Washburn Theodore James Jr.Principal Accounting Officer
Exercise / conversionCommon stock 360 $0.00 $0.00
Disclosure

SEC source: 0001439222-23-000026 · wf-form4_167658147701426.xml · nonDerivative · entry 1

Washburn Theodore James Jr. · CIK 0001874199 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,532

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 21:04 UTC
Burns James WilliamChief Legal Officer
Exercise / conversionRestricted stock units · Derivative 1,738 $0.00 $0.00
Disclosure

SEC source: 0001439222-23-000025 · wf-form4_167658143694129.xml · derivative · entry 3

Burns James William · CIK 0001900772 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common stock · 1,738 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments.

F2 · derivative.expiration_date: The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 21:04 UTC
Burns James WilliamChief Legal Officer
Exercise / conversionCommon stock 1,738 $0.00 $0.00
Disclosure

SEC source: 0001439222-23-000025 · wf-form4_167658143694129.xml · nonDerivative · entry 1

Burns James William · CIK 0001900772 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,147

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 13, 2023 Filed Feb 15, 2023 21:03 UTC Exercise / conversionStock option (right to buy) · Derivative 20,000 $0.00 Strike: $9.05 $0.00
Disclosure

SEC source: 0001439222-23-000020 · wf-form4_167649497047928.xml · derivative · entry 5

Schenkein David P · CIK 0001578200 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,363

Underlying: Common stock · 20,000 shares

Expires 2023-04-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F6 · derivative.exercise_date: This option was originally granted on April 30, 2013 for the purchase of 136,363 shares of common stock. The option vests as to 50% of the underlying shares upon the achievement of a performance milestone, and as to the remaining 50% of upon the achievement of a second performance milestone. The Company's board of directors determined that the first performance milestone was achieved on December 3, 2015, resulting in the vesting of this option as to 68,181 shares. On January 26, 2017, the Company's board of directors determined that the second performance milestone was achieved, resulting in the vesting of this option as to the remaining 68,182 shares.

Read SEC document
February 13, 2023 Filed Feb 15, 2023 21:03 UTC SaleCommon stock 20,000 $28.62 $572,400.00
Disclosure

SEC source: 0001439222-23-000020 · wf-form4_167649497047928.xml · nonDerivative · entry 2

Schenkein David P · CIK 0001578200 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,879

F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $28.25 to $28.94. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
February 13, 2023 Filed Feb 15, 2023 21:03 UTC Exercise / conversionCommon stock 20,000 $9.05 $181,000.00
Disclosure

SEC source: 0001439222-23-000020 · wf-form4_167649497047928.xml · nonDerivative · entry 1

Schenkein David P · CIK 0001578200 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,879

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 21:07 UTC
Gheuens SarahChief Medical Officer
Exercise / conversionRestricted stock units · Derivative 2,162 $0.00 $0.00
Disclosure

SEC source: 0001439222-23-000017 · wf-form4_167640880440163.xml · derivative · entry 3

Gheuens Sarah · CIK 0001881190 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,162

Underlying: Common stock · 2,162 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments.

F2 · derivative.expiration_date: The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 21:07 UTC
Gheuens SarahChief Medical Officer
Exercise / conversionCommon stock 2,162 $0.00 $0.00
Disclosure

SEC source: 0001439222-23-000017 · wf-form4_167640880440163.xml · nonDerivative · entry 1

Gheuens Sarah · CIK 0001881190 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,767

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 21:07 UTC
Burns James WilliamChief Legal Officer
Exercise / conversionRestricted stock units · Derivative 1,834 $0.00 $0.00
Disclosure

SEC source: 0001439222-23-000018 · wf-form4_167640884813599.xml · derivative · entry 3

Burns James William · CIK 0001900772 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,833

Underlying: Common stock · 1,834 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments.

F2 · derivative.expiration_date: The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 21:07 UTC
Burns James WilliamChief Legal Officer
Exercise / conversionCommon stock 1,834 $0.00 $0.00
Disclosure

SEC source: 0001439222-23-000018 · wf-form4_167640884813599.xml · nonDerivative · entry 1

Burns James William · CIK 0001900772 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,052

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 21:06 UTC
Washburn Theodore James Jr.Principal Accounting Officer
Exercise / conversionRestricted stock units · Derivative 777 $0.00 $0.00
Disclosure

SEC source: 0001439222-23-000016 · wf-form4_167640875313872.xml · derivative · entry 4

Washburn Theodore James Jr. · CIK 0001874199 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 777

Underlying: Common stock · 777 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F4 · derivative.exercise_date: The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments.

F4 · derivative.expiration_date: The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 21:06 UTC
Washburn Theodore James Jr.Principal Accounting Officer
Exercise / conversionCommon stock 777 $0.00 $0.00
Disclosure

SEC source: 0001439222-23-000016 · wf-form4_167640875313872.xml · nonDerivative · entry 1

Washburn Theodore James Jr. · CIK 0001874199 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,445

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 119 shares purchased through the Company's employee stock purchase plan.

Read SEC document
February 01, 2023 Filed Feb 14, 2023 21:06 UTC
Washburn Theodore James Jr.Principal Accounting Officer
GrantRestricted stock units · Derivative 6,896 $0.00 $0.00
Disclosure

SEC source: 0001439222-23-000016 · wf-form4_167640875313872.xml · derivative · entry 3

Washburn Theodore James Jr. · CIK 0001874199 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,896

Underlying: Common stock · 6,896 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F3 · derivative.exercise_date: The restricted stock units were granted on February 1, 2023. The shares underlying the restricted stock units will vest in full on February 1, 2025.

F3 · derivative.expiration_date: The restricted stock units were granted on February 1, 2023. The shares underlying the restricted stock units will vest in full on February 1, 2025.

Read SEC document
January 30, 2023 Filed Feb 1, 2023 21:04 UTC Exercise / conversionStock option (right to buy) · Derivative 20,000 $0.00 Strike: $9.05 $0.00
Disclosure

SEC source: 0001439222-23-000010 · wf-form4_167528545373635.xml · derivative · entry 6

Schenkein David P · CIK 0001578200 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,363

Underlying: Common stock · 20,000 shares

Expires 2023-04-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F7 · derivative.exercise_date: This option was originally granted on April 30, 2013 for the purchase of 136,363 shares of common stock. The option vests as to 50% of the underlying shares upon the achievement of a performance milestone, and as to the remaining 50% of upon the achievement of a second performance milestone. The Company's board of directors determined that the first performance milestone was achieved on December 3, 2015, resulting in the vesting of this option as to 68,181 shares. On January 26, 2017, the Company's board of directors determined that the second performance milestone was achieved, resulting in the vesting of this option as to the remaining 68,182 shares.

Read SEC document
January 30, 2023 Filed Feb 1, 2023 21:04 UTC SaleCommon stock 3,300 $29.88 $98,604.00
Disclosure

SEC source: 0001439222-23-000010 · wf-form4_167528545373635.xml · nonDerivative · entry 3

Schenkein David P · CIK 0001578200 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,879

F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F4 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $29.71 to $30.32. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
January 30, 2023 Filed Feb 1, 2023 21:04 UTC SaleCommon stock 16,700 $29.22 $487,974.00
Disclosure

SEC source: 0001439222-23-000010 · wf-form4_167528545373635.xml · nonDerivative · entry 2

Schenkein David P · CIK 0001578200 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121,179

F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $28.69 to $29.69. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
January 30, 2023 Filed Feb 1, 2023 21:04 UTC Exercise / conversionCommon stock 20,000 $9.05 $181,000.00
Disclosure

SEC source: 0001439222-23-000010 · wf-form4_167528545373635.xml · nonDerivative · entry 1

Schenkein David P · CIK 0001578200 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,879

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
January 17, 2023 Filed Jan 19, 2023 21:03 UTC Exercise / conversionStock option (right to buy) · Derivative 20,000 $0.00 Strike: $9.05 $0.00
Disclosure

SEC source: 0001439222-23-000008 · wf-form4_167416220784481.xml · derivative · entry 6

Schenkein David P · CIK 0001578200 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,363

Underlying: Common stock · 20,000 shares

Expires 2023-04-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F7 · derivative.exercise_date: This option was originally granted on April 30, 2013 for the purchase of 136,363 shares of common stock. The option vests as to 50% of the underlying shares upon the achievement of a performance milestone, and as to the remaining 50% of upon the achievement of a second performance milestone. The Company's board of directors determined that the first performance milestone was achieved on December 3, 2015, resulting in the vesting of this option as to 68,181 shares. On January 26, 2017, the Company's board of directors determined that the second performance milestone was achieved, resulting in the vesting of this option as to the remaining 68,182 shares.

Read SEC document
January 17, 2023 Filed Jan 19, 2023 21:03 UTC SaleCommon stock 1,034 $29.49 $30,492.66
Disclosure

SEC source: 0001439222-23-000008 · wf-form4_167416220784481.xml · nonDerivative · entry 3

Schenkein David P · CIK 0001578200 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,879

F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F4 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $29.42 to $29.65. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
January 17, 2023 Filed Jan 19, 2023 21:03 UTC SaleCommon stock 18,966 $28.82 $546,600.12
Disclosure

SEC source: 0001439222-23-000008 · wf-form4_167416220784481.xml · nonDerivative · entry 2

Schenkein David P · CIK 0001578200 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,913

F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $28.42 to $29.39. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
January 17, 2023 Filed Jan 19, 2023 21:03 UTC Exercise / conversionCommon stock 20,000 $9.05 $181,000.00
Disclosure

SEC source: 0001439222-23-000008 · wf-form4_167416220784481.xml · nonDerivative · entry 1

Schenkein David P · CIK 0001578200 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,879

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
January 13, 2023 Filed Jan 18, 2023 21:09 UTC GiftCommon stock 2,200 $0.00 $0.00
Disclosure

SEC source: 0001439222-23-000006 · wf-form4_167407612959834.xml · nonDerivative · entry 1

Foster-Cheek Kaye I · CIK 0001312622 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,549

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:11 UTC
Milanova TsvetaChief Commercial Officer
GrantRestricted stock units · Derivative 25,426 $0.00 $0.00
Disclosure

SEC source: 0001439222-23-000004 · wf-form4_167295304325378.xml · derivative · entry 2

Milanova Tsveta · CIK 0001957180 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,426

Underlying: Common stock · 25,426 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F3 · derivative.exercise_date: The restricted stock units were granted on January 3, 2023. Beginning on January 3, 2024, the shares underlying the restricted stock units will vest in three equal annual installments.

F3 · derivative.expiration_date: The restricted stock units were granted on January 3, 2023. Beginning on January 3, 2024, the shares underlying the restricted stock units will vest in three equal annual installments.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:11 UTC
Milanova TsvetaChief Commercial Officer
GrantStock option (right to buy) · Derivative 135,682 $0.00 Strike: $27.53 $0.00
Disclosure

SEC source: 0001439222-23-000004 · wf-form4_167295304325378.xml · derivative · entry 1

Milanova Tsveta · CIK 0001957180 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,682

Underlying: Common stock · 135,682 shares

Expires 2033-01-03

F1 · derivative.exercise_date: This option was granted on January 3, 2023. The shares underlying this option vest as to 25% of the underlying shares on January 3, 2024, with the remaining 75% vesting in 36 equal monthly installments thereafter.

Read SEC document
December 28, 2022 Filed Dec 28, 2022 21:05 UTC
Gheuens SarahChief Medical Officer
Tax withholdingCommon stock 2,783 $28.48 $79,259.84
Disclosure

SEC source: 0001439222-22-000104 · wf-form4_167226148971361.xml · nonDerivative · entry 2

Gheuens Sarah · CIK 0001881190 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,605

Read SEC document
December 28, 2022 Filed Dec 28, 2022 21:05 UTC
Burns James WilliamChief Legal Officer
Tax withholdingCommon stock 2,597 $28.48 $73,962.56
Disclosure

SEC source: 0001439222-22-000105 · wf-form4_167226150591374.xml · nonDerivative · entry 2

Burns James William · CIK 0001900772 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,218

Read SEC document
December 23, 2022 Filed Dec 28, 2022 21:05 UTC
Gheuens SarahChief Medical Officer
Exercise / conversionRestricted stock units · Derivative 9,375 $0.00 $0.00
Disclosure

SEC source: 0001439222-22-000104 · wf-form4_167226148971361.xml · derivative · entry 3

Gheuens Sarah · CIK 0001881190 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common stock · 9,375 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units were granted on December 23, 2020. The shares underlying the restricted stock units will vest in full on December 23, 2022.

F2 · derivative.expiration_date: The restricted stock units were granted on December 23, 2020. The shares underlying the restricted stock units will vest in full on December 23, 2022.

Read SEC document
December 23, 2022 Filed Dec 28, 2022 21:05 UTC
Gheuens SarahChief Medical Officer
Exercise / conversionCommon stock 9,375 $0.00 $0.00
Disclosure

SEC source: 0001439222-22-000104 · wf-form4_167226148971361.xml · nonDerivative · entry 1

Gheuens Sarah · CIK 0001881190 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,388

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 23, 2022 Filed Dec 28, 2022 21:05 UTC
Burns James WilliamChief Legal Officer
Exercise / conversionRestricted stock units · Derivative 8,750 $0.00 $0.00
Disclosure

SEC source: 0001439222-22-000105 · wf-form4_167226150591374.xml · derivative · entry 3

Burns James William · CIK 0001900772 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common stock · 8,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F3 · derivative.exercise_date: The restricted stock units were granted on December 23, 2020. The shares underlying the restricted stock units will vest in full on December 23, 2022.

F3 · derivative.expiration_date: The restricted stock units were granted on December 23, 2020. The shares underlying the restricted stock units will vest in full on December 23, 2022.

Read SEC document
December 23, 2022 Filed Dec 28, 2022 21:05 UTC
Burns James WilliamChief Legal Officer
Exercise / conversionCommon stock 8,750 $0.00 $0.00
Disclosure

SEC source: 0001439222-22-000105 · wf-form4_167226150591374.xml · nonDerivative · entry 1

Burns James William · CIK 0001900772 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,815

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 272 shares purchased through the Company's employee stock purchase plan.

Read SEC document
December 06, 2022 Filed Dec 6, 2022 21:14 UTC
Gheuens SarahChief Medical Officer
Tax withholdingCommon stock 248 $28.83 $7,149.84
Disclosure

SEC source: 0001439222-22-000101 · wf-form4_167036124284100.xml · nonDerivative · entry 2

Gheuens Sarah · CIK 0001881190 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,013

Read SEC document
December 02, 2022 Filed Dec 6, 2022 21:14 UTC
Gheuens SarahChief Medical Officer
Exercise / conversionRestricted stock units · Derivative 833 $0.00 $0.00
Disclosure

SEC source: 0001439222-22-000101 · wf-form4_167036124284100.xml · derivative · entry 3

Gheuens Sarah · CIK 0001881190 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common stock · 833 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F3 · derivative.exercise_date: The restricted stock units were granted on December 2, 2019. Beginning on December 2, 2020, the shares underlying the restricted stock units will vest in three equal annual installments.

F3 · derivative.expiration_date: The restricted stock units were granted on December 2, 2019. Beginning on December 2, 2020, the shares underlying the restricted stock units will vest in three equal annual installments.

Read SEC document
December 02, 2022 Filed Dec 6, 2022 21:14 UTC
Gheuens SarahChief Medical Officer
Exercise / conversionCommon stock 833 $0.00 $0.00
Disclosure

SEC source: 0001439222-22-000101 · wf-form4_167036124284100.xml · nonDerivative · entry 1

Gheuens Sarah · CIK 0001881190 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,261

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 660 shares purchased through the Company's employee stock purchase plan.

Read SEC document
October 17, 2022 Filed Oct 18, 2022 20:17 UTC
Poddar RichaChief Commercial Officer
Tax withholdingCommon stock 1,485 $27.48 $40,807.80
Disclosure

SEC source: 0001439222-22-000091 · wf-form4_166612418262958.xml · nonDerivative · entry 2

Poddar Richa · CIK 0001897274 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,508

Read SEC document
October 15, 2022 Filed Oct 18, 2022 20:17 UTC
Poddar RichaChief Commercial Officer
Exercise / conversionRestricted stock units · Derivative 5,000 $0.00 $0.00
Disclosure

SEC source: 0001439222-22-000091 · wf-form4_166612418262958.xml · derivative · entry 3

Poddar Richa · CIK 0001897274 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common stock · 5,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F3 · derivative.exercise_date: The restricted stock units were granted on October 15, 2020. The shares underlying the restricted stock units will vest in full on October 15, 2022.

F3 · derivative.expiration_date: The restricted stock units were granted on October 15, 2020. The shares underlying the restricted stock units will vest in full on October 15, 2022.

Read SEC document
October 15, 2022 Filed Oct 18, 2022 20:17 UTC
Poddar RichaChief Commercial Officer
Exercise / conversionCommon stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001439222-22-000091 · wf-form4_166612418262958.xml · nonDerivative · entry 1

Poddar Richa · CIK 0001897274 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,993

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 312 shares purchased through the Company's employee stock purchase plan.

Read SEC document
September 26, 2022 Filed Sep 28, 2022 20:10 UTC
Jones CeciliaChief Financial Officer
GrantRestricted stock units · Derivative 22,417 $0.00 $0.00
Disclosure

SEC source: 0001439222-22-000089 · wf-form4_166439584185254.xml · derivative · entry 2

Jones Cecilia · CIK 0001840056 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,417

Underlying: Common stock · 22,417 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F3 · derivative.exercise_date: The restricted stock units were granted on September 26, 2022. Beginning on September 26, 2023, the shares underlying the restricted stock units will vest in three equal annual installments.

F3 · derivative.expiration_date: The restricted stock units were granted on September 26, 2022. Beginning on September 26, 2023, the shares underlying the restricted stock units will vest in three equal annual installments.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.